Emerging roles of DDB2 in cancer - Université de Lorraine Access content directly
Journal Articles International Journal of Molecular Sciences Year : 2019

Emerging roles of DDB2 in cancer

Abstract

Damage-specific DNA-binding protein 2 (DDB2) was originally identified as a DNA damage recognition factor that facilitates global genomic nucleotide excision repair (GG-NER) in human cells. DDB2 also contributes to other essential biological processes such as chromatin remodeling, gene transcription, cell cycle regulation, and protein decay. Recently, the potential of DDB2 in the development and progression of various cancers has been described. DDB2 activity occurs at several stages of carcinogenesis including cancer cell proliferation, survival, epithelial to mesenchymal transition, migration and invasion, angiogenesis, and cancer stem cell formation. In this review, we focus on the current state of scientific knowledge regarding DDB2 biological effects in tumor development and the underlying molecular mechanisms. We also provide insights into the clinical consequences of DDB2 activity in cancers.

Domains

Cancer
Fichier principal
Vignette du fichier
ijms-20-05168.pdf (1.05 Mo) Télécharger le fichier
Origin : Publisher files allowed on an open archive

Dates and versions

hal-02325073 , version 1 (25-10-2023)

Licence

Attribution

Identifiers

Cite

Pauline Gilson, Guillaume Drouot, Andréa Witz, Jean-Louis Merlin, Philippe Becuwe, et al.. Emerging roles of DDB2 in cancer. International Journal of Molecular Sciences, 2019, 20 (20), pp.5168. ⟨10.3390/ijms20205168⟩. ⟨hal-02325073⟩
81 View
2 Download

Altmetric

Share

Gmail Facebook X LinkedIn More